Logo image of DLB

DOLBY LABORATORIES INC-CL A (DLB) Stock Fundamental Analysis

NYSE:DLB - US25659T1079 - Common Stock

72.64 USD
-0.15 (-0.21%)
Last: 9/5/2025, 8:08:37 PM
72.64 USD
0 (0%)
After Hours: 9/5/2025, 8:08:37 PM
Fundamental Rating

7

Taking everything into account, DLB scores 7 out of 10 in our fundamental rating. DLB was compared to 280 industry peers in the Software industry. DLB gets an excellent profitability rating and is at the same time showing great financial health properties. DLB has a correct valuation and a medium growth rate.


Dividend Valuation Growth Profitability Health

8

1. Profitability

1.1 Basic Checks

DLB had positive earnings in the past year.
In the past year DLB had a positive cash flow from operations.
DLB had positive earnings in each of the past 5 years.
Each year in the past 5 years DLB had a positive operating cash flow.
DLB Yearly Net Income VS EBIT VS OCF VS FCFDLB Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 100M 200M 300M 400M

1.2 Ratios

Looking at the Return On Assets, with a value of 8.27%, DLB belongs to the top of the industry, outperforming 81.79% of the companies in the same industry.
Looking at the Return On Equity, with a value of 10.15%, DLB is in the better half of the industry, outperforming 77.14% of the companies in the same industry.
DLB's Return On Invested Capital of 8.51% is amongst the best of the industry. DLB outperforms 81.07% of its industry peers.
Measured over the past 3 years, the Average Return On Invested Capital for DLB is below the industry average of 12.00%.
The 3 year average ROIC (8.02%) for DLB is below the current ROIC(8.51%), indicating increased profibility in the last year.
Industry RankSector Rank
ROA 8.27%
ROE 10.15%
ROIC 8.51%
ROA(3y)7.33%
ROA(5y)7.98%
ROE(3y)9.1%
ROE(5y)9.75%
ROIC(3y)8.02%
ROIC(5y)8.2%
DLB Yearly ROA, ROE, ROICDLB Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2 4 6 8 10

1.3 Margins

DLB has a Profit Margin of 19.62%. This is amongst the best in the industry. DLB outperforms 83.93% of its industry peers.
DLB's Profit Margin has been stable in the last couple of years.
With an excellent Operating Margin value of 21.47%, DLB belongs to the best of the industry, outperforming 87.86% of the companies in the same industry.
In the last couple of years the Operating Margin of DLB has declined.
The Gross Margin of DLB (88.52%) is better than 95.00% of its industry peers.
DLB's Gross Margin has been stable in the last couple of years.
Industry RankSector Rank
OM 21.47%
PM (TTM) 19.62%
GM 88.52%
OM growth 3Y-7.9%
OM growth 5Y-2.56%
PM growth 3Y-5.31%
PM growth 5Y0%
GM growth 3Y-0.33%
GM growth 5Y0.44%
DLB Yearly Profit, Operating, Gross MarginsDLB Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 20 40 60 80

9

2. Health

2.1 Basic Checks

The Return on Invested Capital (ROIC) is below the Cost of Capital (WACC), so DLB is destroying value.
The number of shares outstanding for DLB has been reduced compared to 1 year ago.
Compared to 5 years ago, DLB has less shares outstanding
DLB has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
DLB Yearly Shares OutstandingDLB Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M 80M 100M
DLB Yearly Total Debt VS Total AssetsDLB Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 1B 2B 3B

2.2 Solvency

An Altman-Z score of 9.30 indicates that DLB is not in any danger for bankruptcy at the moment.
With an excellent Altman-Z score value of 9.30, DLB belongs to the best of the industry, outperforming 86.43% of the companies in the same industry.
There is no outstanding debt for DLB. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF 0
Altman-Z 9.3
ROIC/WACC0.77
WACC11.12%
DLB Yearly LT Debt VS Equity VS FCFDLB Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 500M 1B 1.5B 2B 2.5B

2.3 Liquidity

DLB has a Current Ratio of 3.44. This indicates that DLB is financially healthy and has no problem in meeting its short term obligations.
DLB has a better Current ratio (3.44) than 80.71% of its industry peers.
DLB has a Quick Ratio of 3.36. This indicates that DLB is financially healthy and has no problem in meeting its short term obligations.
DLB has a better Quick ratio (3.36) than 80.00% of its industry peers.
Industry RankSector Rank
Current Ratio 3.44
Quick Ratio 3.36
DLB Yearly Current Assets VS Current LiabilitesDLB Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 500M 1B 1.5B

4

3. Growth

3.1 Past

DLB shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 11.81%, which is quite good.
The Earnings Per Share has been growing by 9.26% on average over the past years. This is quite good.
DLB shows a small growth in Revenue. In the last year, the Revenue has grown by 6.94%.
DLB shows a small growth in Revenue. Measured over the last years, the Revenue has been growing by 0.51% yearly.
EPS 1Y (TTM)11.81%
EPS 3Y1.08%
EPS 5Y9.26%
EPS Q2Q%9.86%
Revenue 1Y (TTM)6.94%
Revenue growth 3Y-0.2%
Revenue growth 5Y0.51%
Sales Q2Q%9.25%

3.2 Future

Based on estimates for the next years, DLB will show a small growth in Earnings Per Share. The EPS will grow by 6.93% on average per year.
Based on estimates for the next years, DLB will show a small growth in Revenue. The Revenue will grow by 5.18% on average per year.
EPS Next Y5.25%
EPS Next 2Y5.99%
EPS Next 3Y6.93%
EPS Next 5YN/A
Revenue Next Year5.5%
Revenue Next 2Y5.03%
Revenue Next 3Y5.18%
Revenue Next 5YN/A

3.3 Evolution

When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
DLB Yearly Revenue VS EstimatesDLB Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 500M 1B 1.5B
DLB Yearly EPS VS EstimatesDLB Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 1 2 3 4

6

4. Valuation

4.1 Price/Earnings Ratio

Based on the Price/Earnings ratio of 17.85, the valuation of DLB can be described as rather expensive.
79.64% of the companies in the same industry are more expensive than DLB, based on the Price/Earnings ratio.
When comparing the Price/Earnings ratio of DLB to the average of the S&P500 Index (27.06), we can say DLB is valued slightly cheaper.
DLB is valuated rather expensively with a Price/Forward Earnings ratio of 17.02.
81.43% of the companies in the same industry are more expensive than DLB, based on the Price/Forward Earnings ratio.
When comparing the Price/Forward Earnings ratio of DLB to the average of the S&P500 Index (22.69), we can say DLB is valued slightly cheaper.
Industry RankSector Rank
PE 17.85
Fwd PE 17.02
DLB Price Earnings VS Forward Price EarningsDLB Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30 40

4.2 Price Multiples

Compared to the rest of the industry, the Enterprise Value to EBITDA ratio of DLB indicates a rather cheap valuation: DLB is cheaper than 84.29% of the companies listed in the same industry.
Compared to the rest of the industry, the Price/Free Cash Flow ratio of DLB indicates a rather cheap valuation: DLB is cheaper than 87.50% of the companies listed in the same industry.
Industry RankSector Rank
P/FCF 15.89
EV/EBITDA 16.32
DLB Per share dataDLB EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 5 10 15 20 25

4.3 Compensation for Growth

The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates an expensive valuation of the company.
The excellent profitability rating of DLB may justify a higher PE ratio.
PEG (NY)3.4
PEG (5Y)1.93
EPS Next 2Y5.99%
EPS Next 3Y6.93%

6

5. Dividend

5.1 Amount

With a Yearly Dividend Yield of 1.81%, DLB has a reasonable but not impressive dividend return.
DLB's Dividend Yield is rather good when compared to the industry average which is at 59.44. DLB pays more dividend than 96.07% of the companies in the same industry.
Compared to the average S&P500 Dividend Yield of 2.32, DLB is paying slightly less dividend.
Industry RankSector Rank
Dividend Yield 1.81%

5.2 History

The dividend of DLB is nicely growing with an annual growth rate of 9.47%!
DLB has been paying a dividend for at least 10 years, so it has a reliable track record.
DLB has not decreased their dividend for at least 10 years, which is a reliable track record.
Dividend Growth(5Y)9.47%
Div Incr Years10
Div Non Decr Years10
DLB Yearly Dividends per shareDLB Yearly Dividends per shareYearly Dividends per share 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0.2 0.4 0.6 0.8 1

5.3 Sustainability

DLB pays out 46.78% of its income as dividend. This is a bit on the high side, but may be sustainable.
DLB's earnings are growing slower than its dividend. This means the dividend growth is not sustainable.
DP46.78%
EPS Next 2Y5.99%
EPS Next 3Y6.93%
DLB Yearly Income VS Free CF VS DividendDLB Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 100M 200M 300M
DLB Dividend Payout.DLB Dividend Payout, showing the Payout Ratio.DLB Dividend Payout.PayoutRetained Earnings

DOLBY LABORATORIES INC-CL A

NYSE:DLB (9/5/2025, 8:08:37 PM)

After market: 72.64 0 (0%)

72.64

-0.15 (-0.21%)

Chartmill FA Rating
GICS SectorInformation Technology
GICS IndustryGroupSoftware & Services
GICS IndustrySoftware
Earnings (Last)07-31 2025-07-31/amc
Earnings (Next)11-17 2025-11-17/amc
Inst Owners95.4%
Inst Owner Change1.71%
Ins Owners1.09%
Ins Owner Change-1.01%
Market Cap6.96B
Analysts80
Price Target105.06 (44.63%)
Short Float %2.51%
Short Ratio3.73
Dividend
Industry RankSector Rank
Dividend Yield 1.81%
Yearly Dividend1.2
Dividend Growth(5Y)9.47%
DP46.78%
Div Incr Years10
Div Non Decr Years10
Ex-Date08-12 2025-08-12 (0.33)
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)6.5%
Min EPS beat(2)4.74%
Max EPS beat(2)8.26%
EPS beat(4)4
Avg EPS beat(4)8.82%
Min EPS beat(4)4.74%
Max EPS beat(4)15.12%
EPS beat(8)8
Avg EPS beat(8)12.28%
EPS beat(12)10
Avg EPS beat(12)12.86%
EPS beat(16)13
Avg EPS beat(16)11.07%
Revenue beat(2)1
Avg Revenue beat(2)-0.22%
Min Revenue beat(2)-2.79%
Max Revenue beat(2)2.35%
Revenue beat(4)2
Avg Revenue beat(4)-0.08%
Min Revenue beat(4)-2.79%
Max Revenue beat(4)2.35%
Revenue beat(8)3
Avg Revenue beat(8)-0.12%
Revenue beat(12)5
Avg Revenue beat(12)0.14%
Revenue beat(16)5
Avg Revenue beat(16)-0.69%
PT rev (1m)5.64%
PT rev (3m)5.64%
EPS NQ rev (1m)-9.48%
EPS NQ rev (3m)-19.54%
EPS NY rev (1m)-0.25%
EPS NY rev (3m)-0.25%
Revenue NQ rev (1m)-2.66%
Revenue NQ rev (3m)-3.92%
Revenue NY rev (1m)0.44%
Revenue NY rev (3m)0.44%
Valuation
Industry RankSector Rank
PE 17.85
Fwd PE 17.02
P/S 5.17
P/FCF 15.89
P/OCF 14.95
P/B 2.67
P/tB 4.17
EV/EBITDA 16.32
EPS(TTM)4.07
EY5.6%
EPS(NY)4.27
Fwd EY5.88%
FCF(TTM)4.57
FCFY6.29%
OCF(TTM)4.86
OCFY6.69%
SpS14.05
BVpS27.18
TBVpS17.4
PEG (NY)3.4
PEG (5Y)1.93
Profitability
Industry RankSector Rank
ROA 8.27%
ROE 10.15%
ROCE 10.3%
ROIC 8.51%
ROICexc 11.34%
ROICexgc 20.41%
OM 21.47%
PM (TTM) 19.62%
GM 88.52%
FCFM 32.52%
ROA(3y)7.33%
ROA(5y)7.98%
ROE(3y)9.1%
ROE(5y)9.75%
ROIC(3y)8.02%
ROIC(5y)8.2%
ROICexc(3y)11.36%
ROICexc(5y)12.88%
ROICexgc(3y)17.78%
ROICexgc(5y)19.47%
ROCE(3y)9.71%
ROCE(5y)9.93%
ROICexcg growth 3Y-12.75%
ROICexcg growth 5Y-4.71%
ROICexc growth 3Y-18.76%
ROICexc growth 5Y-8.2%
OM growth 3Y-7.9%
OM growth 5Y-2.56%
PM growth 3Y-5.31%
PM growth 5Y0%
GM growth 3Y-0.33%
GM growth 5Y0.44%
F-Score6
Asset Turnover0.42
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF 0
Debt/EBITDA 0
Cap/Depr 28.81%
Cap/Sales 2.04%
Interest Coverage 250
Cash Conversion 121.04%
Profit Quality 165.77%
Current Ratio 3.44
Quick Ratio 3.36
Altman-Z 9.3
F-Score6
WACC11.12%
ROIC/WACC0.77
Cap/Depr(3y)46.09%
Cap/Depr(5y)54.2%
Cap/Sales(3y)3.14%
Cap/Sales(5y)3.93%
Profit Quality(3y)140.69%
Profit Quality(5y)133.53%
High Growth Momentum
Growth
EPS 1Y (TTM)11.81%
EPS 3Y1.08%
EPS 5Y9.26%
EPS Q2Q%9.86%
EPS Next Y5.25%
EPS Next 2Y5.99%
EPS Next 3Y6.93%
EPS Next 5YN/A
Revenue 1Y (TTM)6.94%
Revenue growth 3Y-0.2%
Revenue growth 5Y0.51%
Sales Q2Q%9.25%
Revenue Next Year5.5%
Revenue Next 2Y5.03%
Revenue Next 3Y5.18%
Revenue Next 5YN/A
EBIT growth 1Y17.22%
EBIT growth 3Y-8.08%
EBIT growth 5Y-2.06%
EBIT Next Year26.84%
EBIT Next 3Y13.02%
EBIT Next 5YN/A
FCF growth 1Y45.82%
FCF growth 3Y-8.91%
FCF growth 5Y6.77%
OCF growth 1Y39.63%
OCF growth 3Y-9.93%
OCF growth 5Y-0.03%